Podcast appearances and mentions of jesus perez

Matt and EzRaw discuss the latest in boxing news including:News and NotesLatest on the WBA Lightweight Championship bout between Gervonta “Tank” Davis and Lamont Roach Jr.Errol Spence Jr. Re-enters the WBO Rankings, Paving the Way For Proposed Fundora BoutCounsel For ABC Launches Official Inquiry Into BoxRec Amid WBA Dispute. Gustavo Olivieri Officially Takes the WBO Reins from Francisco “Paco” Valcárcel at WBO Convention. Bob Arum and Turki Alalshikh are reportedly at odds over business practices and public statements. Queensberry Re-signings Cap Huge Year For Promotion. Who has the strongest stable in boxingBeterbiev-Bivol Undercard PPV Flops at the Box Office.IBF Schedules November 5 Purse Bid For Bakole-Kabayel Final Eliminator.Fernando “Puma” Martinez vacated his IBF Super Flyweight Championship so that he can go through with the Kazuto Ioka rematch.WBA Schedules November 8 Purse Bid for Stanionis-Giyasov Title Bout.EzRaw Report Card, Full Card Breakdown, & EZ MoneyRobson Conceição (19-2-1, 9 KOs) vs. O'Shaquie Foster (22-3, 12 KOs), 12 rounds for the WBC Super Featherweight Championship Raymond Muratalla (21-0, 16 KOs) vs. Jesus Perez (25-5, 18 KOs), 10 rounds, lightweight Abraham Nova (23-3, 16 KOs) vs. Humberto Galindo (14-3-2, 11 KOs), 10 rounds, super featherweight Jahi Tucker (12-1-1, 5 KOs) vs. Quilisto Madera (14-5, 9 KOs), 8 rounds, middleweight Damian Knyba (13-0, 7 KOs) vs. Richard Lartey (16-6, 13 KOs), 8 rounds, heavyweight Floyd Schofield (17-0, 12 KOs) vs. Rene Tellez Giron (20-3, 13 KOs), 12 rounds, lightweight Gabriela Fundora (14-0, 6 KOs) vs. Gabriela Celeste Alaniz (15-1, 6 KOs), 10 rounds for the WBC, WBA, WBO and IBF Flyweight Championships Bektemir Melikuziev (14-1, 10 KOs) vs. David Stevens (14-1, 10 KOs), 10 rounds, super middleweightQuick HitsAnd more!Read the latest news at Brunch BoxingThoughts or questions? Email us at brunchboxingqa@gmail.comHosts: Matt, and EzRawSocial: MikeProducer: Huey

Join us as we break down a weekend packed with action, drama, and head-scratchers in the ring! Junior lightweight O'Shaquie Foster edged Robson Conceicao again, claiming the WBC title in a split decision sequel that had more déjà vu than drama. Was this really a two-time win for Foster? We'll dig into why fans are still debating who deserved what and whether Conceicao can find a fresh path forward. Plus, lightweight Raymond Muratalla's explosive rebound and Abraham Nova's frustrating draw against Galindo—what's next for them?Golden Boy Promotions didn't disappoint either. Floyd “Kid Austin” Schofield showed both promise and pitfalls against Rene Tellez Giron, surviving a scare but proving there's work ahead. And we'll touch on Gabriela Fundora's star-making night as she became the youngest undisputed champ, dedicating it to Oscar De La Hoya himself.As the weekend's dust settles, we pivot to previewing Friday night's big matchup on ESPN: Keyshawn Davis vs. Gustavo Lemos. Can Davis make a statement against the battle-tested Lemos, or will the Argentine underdog spoil the party?Catch this stream to catch all the highlights, lowlights, and what's next in the world of boxing. Don't forget to like, subscribe, and join the chat to share your take!0:00 Intro01:30 O'Shaquie Foster vs. Robson Conceicao II16:10 Raymond Muratalla stops Jesus Perez 23:45 Abraham Nova vs Humberto Galindo recap30:10 Jahi Tucker beats Kilo the Kid Madera 35:30 Floyd Schofield vs Rene Tellez Giron recap 43:50 Bek The Bully vs David Stevens 48:20 Gabriela Fundora is a star 54:00 Osleys Iglesias vs. Petro Ivanov56:00 Keyshawn Davis vs. Gustavo Lemos preview01:03:30 Troy Isley vs. Tyler Howard01:05:20 Abdullah Mason vs. Yohan Vasquez01:06:57 Kelvin Davis vs. Yeis Solando, 8 rounds, junior welterweights01:09:29 Ra'eese Aleem vs. Derlyn Hernandez-Gerarldo preview01:10:29 Jaron “Boots” Ennis vs. Karen Chukhadzhian II 01:13:51 Jesse “Bam” Rodriguez vs. Pedro Guevara01:15:53 Khalil Coe vs. Manuel Gallegos01:17:10 Ernesto Mercado vs. Jesus Saracho01:18:17 Zaquin Moses vs. Michael Ruiz01:18:46 Subriel Matias vs. Roberto Ramirez01:19:40 ProBox TV Saturday card preview

Teddy Atlas and co-host Ken Rideout cover the past weekend's action from the UFC and boxing. McCrory vs Carrillo, Ortiz vs Mino, Conceicao vs Foster 2, Schofield vs Tellez Giron, Muratalla vs Perez, Moreno vs Albazi and finishing up with a preview of the Jaron Ennis vs Karen Chukhadzhian rematch.Thanks for being with us. The best way to support is to subscribe, share the episode and check out our sponsors:https://athleticgreens.com/atlashttps://mybookie.ag - use promo code ATLASSUBSCRIBE TO OUR WEEKLY NEWSLETTER HERE:https://newsletter.teddyatlas.com00:00 - Intro 09:46 - Padraig McCrory vs Leonard Carrillo 15:43 - Jamaine Ortiz vs Cristian Mino 25:59 - Robson Conceicao vs O'Shaquie Foster 2 41:30 - Floyd Schofield vs Rene Tellez Giron 1:02:22 - Raymond Muratalla vs Jesus Perez 1:10:49 - Brandon Moreno vs Amir Albazi 1:23:08 - Jaron Ennis vs Karen Chukhadzhian PreviewTEDDY'S AUDIOBOOKAmazon/Audible: https://amzn.to/32104DRiTunes/Apple: https://apple.co/32y813rTHE FIGHT T-SHIRTShttps://teddyatlas.comTEDDY'S SOCIAL MEDIATwitter - http://twitter.com/teddyatlasrealInstagram - http://instagram.com/teddy_atlasTHE FIGHT WITH TEDDY ATLAS SOCIAL MEDIAInstagram - http://instagram.com/thefightWTATwitter - http://twitter.com/thefightwtaFacebook - https://www.facebook.com/TheFightwithTeddyAtlasBig thanks to VHS collection for intro music. More on VHS Collection here: http://www.vhscollection.comThanks for tuning in. Please be sure to subscribe!#boxing #ufc #teddyatlas Hosted on Acast. See acast.com/privacy for more information.

Abraham Gonzalez is the Editor-in-Chief and owner of FightsATW.com, a member the RING Magazine's Ratings' panel, and a member of the Boxing Writers Association of America. He also hosts his own podcast called The Boxing Rush Hour Show. Follow Abraham on

Teddy Atlas and co-host Ken Rideout cover the past weekend's action from the UFC and boxing. McCrory vs Carrillo, Ortiz vs Mino, Conceicao vs Foster 2, Schofield vs Tellez Giron, Muratalla vs Perez, Moreno vs Albazi and finishing up with a preview of the Jaron Ennis vs Karen Chukhadzhian rematch.Thanks for being with us. The best way to support is to subscribe, share the episode and check out our sponsors:https://athleticgreens.com/atlashttps://mybookie.ag - use promo code ATLASSUBSCRIBE TO OUR WEEKLY NEWSLETTER HERE:https://newsletter.teddyatlas.com00:00 - Intro 09:46 - Padraig McCrory vs Leonard Carrillo 15:43 - Jamaine Ortiz vs Cristian Mino 25:59 - Robson Conceicao vs O'Shaquie Foster 2 41:30 - Floyd Schofield vs Rene Tellez Giron 1:02:22 - Raymond Muratalla vs Jesus Perez 1:10:49 - Brandon Moreno vs Amir Albazi 1:23:08 - Jaron Ennis vs Karen Chukhadzhian PreviewTEDDY'S AUDIOBOOKAmazon/Audible: https://amzn.to/32104DRiTunes/Apple: https://apple.co/32y813rTHE FIGHT T-SHIRTShttps://teddyatlas.comTEDDY'S SOCIAL MEDIATwitter - http://twitter.com/teddyatlasrealInstagram - http://instagram.com/teddy_atlasTHE FIGHT WITH TEDDY ATLAS SOCIAL MEDIAInstagram - http://instagram.com/thefightWTATwitter - http://twitter.com/thefightwtaFacebook - https://www.facebook.com/TheFightwithTeddyAtlasBig thanks to VHS collection for intro music. More on VHS Collection here: http://www.vhscollection.comThanks for tuning in. Please be sure to subscribe!#boxing #ufc #teddyatlas Hosted on Acast. See acast.com/privacy for more information.

It's the newest edition of our recap show as host T.J. Rives and insider Dan Rafael of his Fight Freaks Unite Substack are back to go over the action, Dan has a one on one interview with a rising star lightweight and we have some great nostalgia. It's al on the "Fight Freaks Unite Recap Podcast!"The guys recap the Top Rank/ESPN+ card from Saturday at Turning Stone in Verona, NY, as  O'Shaquie Foster regained his WBC 130 lb. title with a split decision over Robson Conceicao. This avenged Foster's controversial loss earlier this Summer. And, also rising lightweight star Raymond Muratalla demolishes Jesus Perez in just two rounds in the co-feature.Next is the Golden Boy/DAZN card from Saturday at Virgin Hotels in Las Vegas, where lightweight Floyd Schofield won but had problems late with veteran Rene Tellez Giron. And, Gabriela Fundora scored a TKO over Gabriela Celeste Alanizs, retaining the IBF, and winning the WBC/WBO/WBA women's flyweight world titles. Fundora has huge upside, obviously.Then, Dan talks with Keyshawn Davis who will have his first hometown fight in Norfolk, Virginia, and his first main event on Friday night's Top Rank ESPN+ card. They go over the Olympian's progress and goals.There's fight news on DAZN and Queensberry announcing Sunday they have joined forces in a deal that will put all of Queensberry's events exclusively on DAZN. And, Gustavo Olivieri, the longtime WBO attorney, was elected president of the sanctioning body on Thursday during its annual convention in Puerto Rico, replacing the retiring Francisco “Paco” Valcarcel, who led the WBO for 30 years.Finally, there's nostalgia for Nov. 3, 2001 – 23 years ago – as future hall of famer Kostya Tszyu scored a wild KO in the 2nd over Zab Judah to become undisputed junior welterweight champion.30 years ago on Tuesday – George Foreman's historic 10th round KO Michael Moorer to regain the heavyweight title in one of the most memorable moments in heavyweight history. And, also, Sunday, November 3rd is the great Larry Holmes' 75th birthday. We reminisce on him, as well.It's all part of the "Fight Freaks Unite Recap Podcast" and make sure to follow/subscribe on Apple/Spreaker/Spotify, etc.

It's the newest edition of our recap show as host T.J. Rives and insider Dan Rafael of his Fight Freaks Unite Substack are back to go over the action, Dan has a one on one interview with a rising star lightweight and we haves some great nostalgia. It's al on the "Fight Freaks Unite Recap Podcast!"The guys recap the Top Rank/ESPN+ card from Saturday at Turning Stone in Verona, NY, as  O'Shaquie Foster regained his WBC 130 lb. title with a split decision over Robson Conceicao. This avenged Foster's controversial loss earlier this Summer. And, also rising lightweight star Raymond Muratalla demolishes Jesus Perez in just two rounds in the co-feature.Next is the Golden Boy/DAZN card from Saturday at Virgin Hotels in Las Vegas, where lightweight Floyd Schofield won but had problems late with veteran Rene Tellez Giron. And, Gabriela Fundora scored a TKO over Gabriela Celeste Alanizs, retaining the IBF, and winning the WBC/WBO/WBA women's flyweight world titles. Fundora has huge upside, obviously.Then, Dan talks with Keyshawn Davis who will have his first hometown fight in Norfolk, Virginia, and his first main event on Friday night's Top Rank ESPN+ card. They go over the Olympian's progress and goals.There's fight news on DAZN and Queensberry announcing Sunday they have joined forces in a deal that will put all of Queensberry's events exclusively on DAZN. And, Gustavo Olivieri, the longtime WBO attorney, was elected president of the sanctioning body on Thursday during its annual convention in Puerto Rico, replacing the retiring Francisco “Paco” Valcarcel, who led the WBO for 30 years.Finally, there's nostalgia for Nov. 3, 2001 – 23 years ago – as future hall of famer Kostya Tszyu scored a wild KO in the 2nd over Zab Judah to become undisputed junior welterweight champion.30 years ago on Tuesday – George Foreman's historic 10th round KO Michael Moorer to regain the heavyweight title in one of the most memorable moments in heavyweight history. And, also, Sunday, November 3rd is the great Larry Holmes' 75th birthday. We reminisce on him, as well.It's all part of the "Fight Freaks Unite Recap Podcast" and make sure to follow/subscribe on Apple/Spreaker/Spotify, etc.

@ray_muratalla1 @toprank #Boxing #muratallaperez --- Support this podcast: https://podcasters.spotify.com/pod/show/marc-abrams7/support

Step into the ring with Chuy for the final Boxing episode of the Season--in Episode #7 of Rings and Cages AZ, where we keep you connected to the pulse of Arizona's boxing and MMA scene. This week, we're shining a spotlight on the dynamic world of Arizona Boxing, bringing you exclusive coverage of the Iron Boy 73 event at Celebrity Theatre, plus a sneak peek at what's coming up at UFL 5: Phoenix vs. Vegas.Chuy kicks things off with a deep dive into the current state of Arizona boxing, recognizing the key players, gyms, and promoters making waves in the scene. Shoutout to Chris Vasquez (@chrisvasquezboxing) of Iron Boy Promotions (@ironboypromotions) for continuing to elevate the sport in our state. We'll also be giving you all of the above-the-belt lowdown on United Fight League's upcoming event, featuring the best of Phoenix vs. Vegas in an MMA showdown at Wild Horse Pass Casino. Don't forget to check out UFL Promotions (@unitedfightleague) for more on what's next in Arizona's combat sports.Segments Covered:Fightin Words: Chuy dives deep into the Arizona boxing scene, recognizing the gyms, fighters, and promoters that make it thrive.The Breakdown: Terraza vs. Perez: How Elias Terraza outpointed Jesus Perez to stay undefeated and what he can learn from this fight.The Breakdown: Rodriguez vs. Cortez: Sergio Rodriguez's impressive display of toughness, power, and confidence in the ring.The Breakdown: Ochoa vs. Angulo: Why Trini Ochoa's relentless activity kept him undefeated against Jose Angulo.Fast As Lightning: Highlighting wins from Cesar Navarro, Kenneth James, Shaquile Felicia, and Da'Marrius Watson at Iron Boy 73.Fight Forecast: Jiu Jitsu Con: Shout out to all the Arizona gyms heading to Las Vegas for Jiu Jitsu Con.Fight Forecast: UFL 5 Phoenix vs. Vegas: A preview of United Fighting League's UFL 5: Phoenix vs. Vegas card.Don't miss this episode packed with exclusive insights, fight breakdowns, and everything you need to stay on top of Arizona's combat sports world. Whether you're a seasoned fan or just stepping into the scene, Rings and Cages AZ is your go-to source for all things fighting in the Copper State.Tune in at https://youtube.com/@RingsAndCagesAZ/podcasts and subscribe to stay connected!#RingsAndCagesAZ #ArizonaBoxing #IronBoy73 #MMA #FightNight #UFL5 #CombatSports #Boxing #JiuJitsuConhttps://linktr.ee/ringsandcagesaz - get plugged in and connected with the growing Arizona Fight Scene Community. We get what we put into it, and we need your help: fighters, promoters, coaches, and fans. Let's take this to the next level.

Episode 303 of the Football Fitness Federation Podcast is with UEFA Pro Sport Scientist and Assistant to Mauricio Pochettino, Jesus Perez⁣ ⁣ We discussed:⁣ ▫️What we can do better in Sport Science⁣ ▫️What he looks for in a Sport Scientist⁣ ▫️His concerns about future match demands⁣ ▫️Recovery⁣ & much more!⁣ ⁣ You can connect with Jesus on X @Jesus_perez⁣ ⁣ If you enjoy this episode make sure to check out the previous episodes below:⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Brett Bartholomew - https://youtu.be/W95WIZXl5u0⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Gareth Sandford & Damien Harper - https://youtu.be/BQUYkihCeD8⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Stu McMillan - https://youtu.be/ya5b3TCm9Ws⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ ⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Keep up to date with the amazing work our sponsors are doing here:⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ ⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ ⁣⁣⁣⁣Good Prep - https://thegoodprep.com⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ ⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Discover the power of nutrition at WWW.THEGOODPREP.COM and use code FFF15 for 15% off your first order⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ ⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Rezzil - rezzil.com⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ ⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Hytro - hytro.com⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ ⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Maximise your athletic potential with Hytro BFR. Easier, safer and more practical BFR for squads to prepare for and recover from exercise than ever before.⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ ⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Click the link [[ https://bit.ly/3ILVsbU ]] to speak to our Pro Sports team about how to get Hytro BFR at your club.⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ ⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Join our online community & get access to the very best Football Fitness content as well as the ability to connect with Sport Scientists and Strength & Conditioning coaches from around the world.⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ ⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ To get FULL access to all of these & even more like this, sign up to a FREE month on our online community at the link below.⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ ⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ www.footballfitfed.com/forum/index.aspx⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ ⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Keep up to date with everything that is going on at Football Fitness Federation at the following links:⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ ⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Twitter - @FootballFitFed⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Instagram - @FootballFitFed⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣ Website - www.footballfitfed.com⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣⁣

#josephdiaz #goldenboypromotions #oscardelahoya ️️️☎️ Joseph Diaz Jr. vs. Jesus “Ricky” Perez, Adrien Curiel vs. Sivenathi Nontshinga II Previews and Predictions❗️

In this episode, Vinicio de Jesus Perez, MD discusses some of the most recent clinical developments in the field of pulmonary hypertension, highlighting new and ongoing clinical trials that are of great interest to the medical community as well as caregivers and patients looking forward to novel ways of treating their condition. Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Follow us on social @phaware Engage for a cure: www.phaware.global/donate #phaware Share your story: info@phaware.com #phawareMD @PHatStanford  @Viniciodjperez   

In this episode we welcome back my good friend Jesus Perez. We cover different aspects of relationships from a Christian perspective. Email questions and prayer requests to Freeindedshow@gmail.com Backup Email: Freeindeedshow@protonmail.com Thanks for listening! --- Support this podcast: https://podcasters.spotify.com/pod/show/jd-salazar/support

In this episode, we talk with Dr. Zhiyu Dai and Dr. Vinicio de Jesus Perez about pulmonary hypertension, the progress that has been made in this field and what is next to come. This podcast is a production of the NAVBO's education committee.

Me and my good friend kick back and share our thoughts and feelings on modern worship culture, Church and lots of musical opinions. Enjoy! Email questions and prayer requests to Freeindeedshow@gmail.com Backup Email: Freeindeedshow@protonmail.com find my friend at 4J_music on Youtube --- Support this podcast: https://podcasters.spotify.com/pod/show/jd-salazar/support

We are starting off season three of Road to the Trials with one of the best and most versatile runners in the U.S. - Nell Rojas. In this episode we talk about her 2022 marathon performances and take a deep dive into the tumultuous last two months of her life that nearly ended her 2023 Boston Marathon before it began. Nell is a professional marathon runner for Nike. She grew up in Boulder, CO with two older brothers and her dog Starblaze. She walked on to the Northern Arizona University cross country and track and field teams and got her B.S. in Exercise Science. After college she became a professional triathlete until she decided to move out of her mom's basement and focus on her coaching career. She discovered marathons when she finished 7th at the 2018 marathon national championships in a time of 2:31. She recently finished 5th at the 2021 Boston Marathon, 10th at the 2022 Boston Marathon, and 10th at the 2022 NYC Marathon. She is the 2021 10 mile national champion.  Nell started coaching with her dad Ric Rojas when she graduated from high school and has been coaching ever since. She and the founder of RISE Boulder and is well known for her strength training for runners.   PR's:  Marathon 2:25:57  10k: 31:52  5k: 15:37 The photo used in the podcast graphic was taken by Jesus Perez - www.instagram.com/weligsander. Sponsor: This episode is sponsored by UCAN nutrition which is powered to deliver steady, long lasting energy without the spike and crash. Add in UCAN Hydrate to get those electrolytes that you need to stay hydrated. Finally, you've got to try the award winning Edge energy gels - they are my go-to on the run. You will get 20% of all of your orders at ucan.co with code RAMBLING and get a free sample pack of six Edge energy gels, you only have to pay the shipping, at www.ucan.co/rambling. _ _ _ Learn more about your ad choices. Visit megaphone.fm/adchoices

We are starting off season three of Road to the Trials with one of the best and most versatile runners in the U.S. - Nell Rojas. In this episode we talk about her 2022 marathon performances and take a deep dive into the tumultuous last two months of her life that nearly ended her 2023 Boston Marathon before it began. Nell is a professional marathon runner for Nike. She grew up in Boulder, CO with two older brothers and her dog Starblaze. She walked on to the Northern Arizona University cross country and track and field teams and got her B.S. in Exercise Science. After college she became a professional triathlete until she decided to move out of her mom's basement and focus on her coaching career. She discovered marathons when she finished 7th at the 2018 marathon national championships in a time of 2:31. She recently finished 5th at the 2021 Boston Marathon, 10th at the 2022 Boston Marathon, and 10th at the 2022 NYC Marathon. She is the 2021 10 mile national champion. Nell started coaching with her dad Ric Rojas when she graduated from high school and has been coaching ever since. She and the founder of RISE Boulder and is well known for her strength training for runners. PR's: Marathon 2:25:57 10k: 31:52 5k: 15:37 The photo used in the podcast graphic was taken by Jesus Perez - www.instagram.com/weligsander.

Today's episode is from the How to Study the Bible Podcast. We are kicking off a new Advent series there, looking at the women in Jesus' lineage in a God of Our Mothers series. In Matthew 1, we get a genealogy of Jesus' family. Genealogies are put in place because the people matter to the story, and there are several women named in his family line. WHAT DOES IT SAY? Matthew 1:1-3: “This is the genealogy of Jesus the Messiah the son of David, the son of Abraham: 2 Abraham was the father of Isaac, Isaac the father of Jacob, Jacob the father of Judah and his brothers, 3 Judah the father of Perez and Zerah, whose mother was Tamar…” Genesis 38 – Who Is Tamar? 1. She is not an Israelite 2. She is unwanted 3. She is mistreated 4. She is seeking justice 5. She is shrewd (Don't forget how Judah's mom came to have him--also veiled and in disguise) Genesis 38:26 is the turning point in the story. Judah confesses his unrighteousness, and we see that Tamar is brought into his family and one of her twin sons becomes part of the lineage that leads to Jesus (Perez). WHAT IS THE BACKSTORY After Joseph is sold into slavery, we get this graphic story in Genesis 38. We see the wickedness of Judah as a foil to Joseph's righteousness. But eventually, we'll see Judah take a righteous turn. First, though, he marries a Canaanite, and they have three sons. One of these sons marries Tamar. WHAT DOES IT MEAN? 1. God colors outside the lines. 2. We are never defined by our past. 3. God sees the marginalized. WHAT DOES IT MEAN FOR ME? Matthew 9:10-12: 10 While Jesus was having dinner at Matthew's house, many tax collectors and sinners came and ate with him and his disciples.11 When the Pharisees saw this, they asked his disciples, “Why does your teacher eat with tax collectors and sinners?” 12 On hearing this, Jesus said, “It is not the healthy who need a doctor, but the sick. 13 But go and learn what this means: ‘I desire mercy, not sacrifice.'[a] For I have not come to call the righteous, but sinners.” FREE Gift from Nicole! Nicole has written a free Christmas Eve liturgy for you and your family: https://www.nicoleunice.com/christmas

We are kicking off a new Advent series! We are going to be looking at the women in Jesus' lineage in a ‘God of Our Mothers' series. In Matthew 1, we get a genealogy of Jesus' family. Genealogies are put in place because the people matter to the story, and there are several women named in his family line. Over the next few weeks, we'll look closely at the women in Jesus' lineage and what they have to teach us about the God who loves us and came to rescue us.This week, we're looking at the story of Tamar.FREE Gift from Nicole!Nicole has written a free Christmas Eve liturgy for you and your family:https://www.nicoleunice.com/christmas*WHAT DOES IT SAY?*Matthew 1:1-3:“This is the genealogy of Jesus the Messiah the son of David, the son of Abraham: 2 Abraham was the father of Isaac, Isaac the father of Jacob, Jacob the father of Judah and his brothers,3 Judah the father of Perez and Zerah, whose mother was Tamar…”Genesis 38 – Who Is Tamar?1. She is not an Israelite2. She is unwanted3. She is mistreated4. She is seeking justice5. She is shrewd(Don't forget how Judah's mom came to have him--also veiled and in disguise)Genesis 38:26 is the turning point in the story. Judah confesses his unrighteousness, and we see that Tamar is brought into his family and one of her twin sons becomes part of the lineage that leads to Jesus (Perez).*WHAT IS THE BACKSTORY*After Joseph is sold into slavery, we get this graphic story in Genesis 38. We see the wickedness of Judah as a foil to Joseph's righteousness. But eventually, we'll see Judah take a righteous turn. First, though, he marries a Canaanite, and they have three sons. One of these sons marries Tamar.*WHAT DOES IT MEAN?*1. God colors outside the lines.2. We are never defined by our past.3. God sees the marginalized.*WHAT DOES IT MEAN FOR ME?*How do we define ourselves? Are we righteous on our own, or sinners on our own? Can we relate to Tamar? If we can relate, we can receive. “I have come for the sick, for the sinners.Matthew 9:10-12: 10 While Jesus was having dinner at Matthew's house, many tax collectors and sinners came and ate with him and his disciples.11 When the Pharisees saw this, they asked his disciples, “Why does your teacher eat with tax collectors and sinners?”12 On hearing this, Jesus said, “It is not the healthy who need a doctor, but the sick. 13 But go and learn what this means: ‘I desire mercy, not sacrifice.'[a] For I have not come to call the righteous, but sinners.”FOLLOW NICOLE:Website: https://nicoleunice.com/ YouTube: https://www.youtube.com/nicoleuniceInstagram: https://www.instagram.com/nicoleunice/Facebook: https://www.facebook.com/nicole.unice/

Matthew interviews the co-founder and artistic director of Chicago Kids Company; Jesus Perez. The two talk about the origins of CKC, Jesus growing up in Puerto Rico, and how he taught himself how to make puppets. Matthew even did this interview in the room where all the magic happens; the Chicago Kids Company office.

Entrevista a  María Jesus Perez, Técnica área xurídica de COGAMI (01/09/2022)

Undefeated Lightweight Victor Padilla drops by to talk about his May 20th fight with Jesus Perez in Philadelphia. Also joining the Interview is The Philly Godfather @loudibella @dibellaent #Boxing #PadillaPerez @2300arena #philadelphia @phillygodfather --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/marc-abrams7/support

Puedes seguir al Doctor Jesús en: https://scholar.google.com.mx/citations?user=KjCEO5gAAAAJ&hl=es https://www.researchgate.net/profile/Jesus-Perez-27 Facebook: Jesus Perez Moren  (sic)***Escríbenos a: Dra. Mariana Elizondo -- marianaelizertuche@gmail.comDr. Efrén Robledo -- efrenjo@gmail.com

Jesus Perez(he/him) shares highlights from his multi-faceted career as a designer, director, actor, and writer. Hear of Jesus's beginnings and breakouts as an actor, what led to his eventual work as an award-winning costume designer and how the long-standing Chicago Kids Company got their start- where he has served as Artistic Director for nearly 30 years. Support the show (https://venmo.com/code?user_id=1837075473104896781&created=1645757023.227347&printed=1)

Tema: TIRA LA CAPA Conéctate y disfruta de esta increíble palabra del Señor! || Connect with us and enjoy this incredible word from the Lord!

En dialogo con JESUS PEREZ , de la Asociación de Pescadores , charlamos sobre el beneficio que recibirán los pescadores tras darse a conocer la noticia de que se implementará un nuevo día a la semana de veda.

We chat with wrestling coach Jake Patacsil, a former All-American at Purdue and St. Thomas Aquinas High school grad in Fort Lauderdale, about getting the school's new program off the ground. Jesus Perez, the team's first signee who wrestles in the 197-pound weight class, talks to us about his path from Hialeah Gardens to minus-30 degree temperatures for college wrestling and then his trip back home to help start STU's new program. Plus, media relations coordinator Jonathan Leatherman stops by to share his insights on the other programs at STU and how they are doing during this football bye week. 36 minutes. Oct. 14, 2020. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/frontpage305/message Support this podcast: https://anchor.fm/frontpage305/support

Data plays an increasing role in elite sports performance management. We chatted to Jesus Perez, assistant manager to Mauricio Pochettino at Tottenham Hotspur for five years, and Zone7’s Tal Brown about data informed decision making.Both set out that context is king. Someone needs to analyse the data. Coaches, like Perez and Pochettino, are the point at which data sets merge and decisions are needed. If done well, clubs can save money because their players are not picking up wages while injured, estimated at £35m a year in the Premier League. They discuss how managers have to be held accountable for players getting injured if the data said they needed a rest. Tal said: “when I'm asked by investors in Silicon Valley ‘why are you in sports, it's not a very big market? There are no sports teams in the Fortune 500.’ My answer is that if you want to create technology for human performance, you need data about it and going back 2, 3, 4 years, the only the only industry that had this kind of data at scale consistently is sports.” Jesus discusses how he has used data to understand players and gives examples from his time at some of the biggest clubs in England and Spain.

Welcome to the first episode of Between The Lines with Melissa Reddy, a new podcast bringing you unrivalled insight and fascinating stories from some of the biggest names in football. Today, Melissa is joined by former Tottenham, Southampton and Espanyol manager Mauricio Pochettino and his trusted assistant, Jesus Perez. The pair discuss how their professional and personal lives have changed since leaving Spurs, reveal the important factors they'll consider when choosing their next club, and underline why a human touch is central to their approach. Mauricio and Jesus also share their reaction to watching Spurs' new All Or Nothing documentary, and their surprise at only featuring in the first 25 minutes of episode one!***Please take the time to rate and review us on Apple Podcasts or wherever you get your pods. It means a great deal to the show and will make it easier for other potential listeners to find us. Thanks!*** See acast.com/privacy for privacy and opt-out information.

1st St Thomas University Wrestling Signee in school history Former Asst Coach at Barbara Goleman HS Wrestled previously at Iowa Central CC under Luke Moffitt & University of the Ozarks under Leroy Gardner Currently a Junior at St Thomas University wrestling under Jake Patascil --- Support this podcast: https://anchor.fm/daniel-ward9/support

Dr. Vinicio de Jesus Perez is an associate professor of pulmonary and critical care medicine at Stanford University, and practicing cardiopulmonologist who specializes in research and the clinical care of patients with pulmonary hypertension. He joins the show today to discuss the details of this interesting and important career, including the following: What the difference is between systemic hypertension and pulmonary hypertension How pulmonary hypertension has emerged as an increasingly common and complex disease since the 1960s, and what signs and symptoms patients generally present with What drugs and interventions can be used to treat different forms of pulmonary hypertension, and the importance of educating and supporting medical professionals in this area Dr. De Jesus Perez begins by illustrating the road that led him to pursue a path of medicine in the field of cardiopulmonology and critical care. He details one of the most difficult and memorable patients he saw in his early days as a medical intern, and how the experience spurred his desire to dive more deeply into an understanding of pulmonary hypertension. He explains the fascinating and somewhat unusual uptick in the number of cases of pulmonary hypertension in the 1960s in correlation with a weight loss drug called aminorex, and the discovery that pulmonary hypertension can be both a disease on its own as well as a complication of other disease processes, including lung fibrosis, left heart failure, kidney failure, HIV, and scleroderma. In order to meet the needs of patients with pulmonary hypertension and properly equip medical professionals for dealing with the disease, Dr. De Jesus Perez's group was one of the first to establish a pulmonary fellowship program aimed at training professionals to understand, diagnose, and treat pulmonary hypertension. Tune in to hear the full conversation and learn about the many resources for additional information on pulmonary hypertension, including http://med.stanford.edu/wallcenter.html.

In this episode, Dr. Perez discusses the diagnostic evaluation of the patient with pulmonary hypertension at the clinic. Vinicio de Jesus Perez, MD is Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF.  Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD @PHatStanford 

In this episode, Dr. Perez discusses ongoing clinical studies in #pulmonaryhypertension and what that means for practitioners & patients with PH. Vinicio de Jesus Perez, MD is Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF.  Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD @PHatStanford 

Doctor Juan de Jesus Perez testimonio omnilife 2020

Today we sit down with principal and YouTube star John Anzalone (Johnny Eats) to talk about the ins and outs of running a high school in Las Vegas.

The trailer for my first season of ¿Ya Saludastes?, a Chicago neighborhood podcast. Stay tuned for our first episode of our first season, focusing on the Chicago neighborhood of Pilsen. Follow me on Instagram! @yasaludastes Logo provided by Jesus Perez at Ace in the Hole Signs and Graphix (Look for them on Facebook, Ace in the Hole Signs and Graphix) Music provided by Mama Patxanga, El Remelon and Radio Jarocho/ Zenen Zeferino Huervo. All tracks came from the Free Music Archive at freemusicarchive.org ¿Ya Saludastes? is sponsored by Anchor.fm. Anchor makes it easy to create and distribute your podcasts. Go to anchor.fm to learn more. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

Beyond The Game Correspondent Lance Santos sat down with Spurs' Assistant Manager Jesus Perez this week and talked about Wednesday's remarkable victory over Manchester City, their next Champions League match against Ajax and how influential Mauricio Pochettino is for Spurs. Beyond The Game is a five times a week show that tells you everything you need to know about your favourite sports. We’ll be at the biggest events bringing you exclusive features and the best interviews. It is your one stop shop for sport, Monday to Friday at 1630 GMT. Beyond The Game: http://trt.world/beyondthegame #TottenhamInterview #TottenhamChampionsLeague #TottenhamManchesterCity

 Dr Carolyn Lam:               Welcome to Circulation on the Run, your weekly podcast summary and backstage pass to The Journal and its editors. I'm Dr Carolyn Lam, associate editor from the National Heart Center, and Duke National University of Singapore. Dr Greg Hundley:             And I'm Greg Hundley, also associate editor in Richmond, Virginia at VCU Health.  Dr Carolyn Lam:               So, PCI or no PCI for chronic total occlusion. That is a perennial question, and we have the results of the decision CTO trial reported in this week's Journal. In fact, we're going to discuss it right after our little chat here.                                                 So, Greg, why don't you kick us off? What paper did you choose?  Dr Greg Hundley:            Yeah, thanks so much Carolyn. My first paper is from Laura Benschop from the Department of Obstetrics and Gynecology at Erasmus Medical Center in Rotterdam, the Netherlands. It's going to focus on placental growth factor as an indicator of maternal cardiovascular risk after pregnancy.                                                 So, as we all know, pregnancy is accompanied by extensive maternal hemodynamic changes that allow for proper placental implantation, growth, profusion, and fetal development and this process requires a tight balance between pro-angiogenic factors like placental growth factor, and anti-angiogenic factors like soluble FMS like tyrosine kinase factors. So, in response to stress, the syncytiotrophoblast will decrease the production of placental growth factor and women with reduced placental growth factor and increased FLT-1, are more at risk of a complicated pregnancy. For example, like preeclampsia and spontaneous preterm birth.                                                 So, angiogenic placental growth factor concentrations can rise during pregnancy, peaking at the end of the mid-pregnancy. And low placental growth factor concentrations during pregnancy are associated with pregnancy complications with recognized later life cardiovascular risk. So here, the authors hypothesize that low placental growth factor concentrations, especially in mid pregnancy, identify not only a subset of women at risk for pregnancy complications, but also women with greater cardiovascular risk factor burden after pregnancy, regardless of their outcome.                                                 So, among 5,529 women, the authors computed gestational age adjusted and mid-pregnancy placental growth factor concentrations and pregnancy complications, like preeclampsia, small for gestational age, spontaneous preterm birth, was obtained from hospital registries.  Dr Carolyn Lam:               Cool, and what did they find?  Dr Greg Hundley:            So six years after pregnancy, the authors found that women with mid pregnancy low placental growth factors, in the lowest quartile, had larger aortic diameters, left atrial diameters, and LV mass, and a higher systolic blood pressure by an average of 2.3 millimeters of mercury. High mid-pregnancy placental growth factor concentrations were the opposite. They were associated with smaller aortic diameters, smaller left atrial diameters, lower LV mass by 3.9 grams, and lower systolic blood pressure. And these differences persisted after exclusion of women with complicated pregnancies.                                                 So, the results suggest that a woman's response to the cardiovascular changes of pregnancy, measured by pre-mid-pregnancy placental growth factor levels could provide insight into the path of physiological mechanisms leading to future cardiovascular disease in multiparous women.  Dr Carolyn Lam:               Wow. That is really interesting. Well, the paper I chose really answers the question, are there racial differences in sudden cardiac death, and why? And this is from corresponding author Dr Guallar from Welch Center for Prevention, Epidemiology, and Clinical Research in Johns Hopkins Bloomberg School of Public Health and Colleagues.                                                 What they did is they compared the lifetime cumulative risk of sudden cardiac death among blacks and whites in the atherosclerosis risk in community study, or ARIC. They evaluated the risk factors that may explain racial differences in sudden cardiac death risk in this general population.                                                 What they found was that blacks had a much higher risk of sudden cardiac death in comparison with whites, with a sex adjusted hazards ratio of 2.12. Known factors explained 65% of the axis risk of sudden cardiac death in blacks compared to whites. The single most important factor explaining this difference was income, followed by education, hypertension, and diabetes. These racial differences were evident in both genders, but stronger in women than men.  Dr Greg Hundley:            Hmm. So are there implications, and are there potential strategies that could help reduce this risk in African Americans?  Dr Carolyn Lam:               Yeah, this is a really interesting study, and it really implies that efforts to reduce the sudden cardiac risk in blacks should perhaps focus on improving CPR outreach, medical care engagement in response to cardiac arrest, the quality of treatment in medical institutions in predominantly black neighborhoods, and factors such as that. Because remember the single most important factor explaining the difference was actually income and education.  Dr Greg Hundley:            Oh, wow. Well, I'm going to switch gears a little bit here Carolyn, and we're going to talk about pulmonary hypertension. And this next paper is going to focus on pericytes. We'll learn a little bit about what pericytes are. So, the paper is from Vinicio de Jesus Perez, who's an assistant professor of medicine and pulmonary critical care at Stanford University Medical Center in California.                                                 What are pericytes? So, pericytes are specialized perivascular cells embedded in the basement membrane of blood vessels, where in conjunction with neighboring and endothelial cells, they support vessel maturation and stability. In the lung, pericytes are mostly found associated with small precapillary arteries, the capillaries, and then those post capillary venules. And it's thought that pericytes are responsible for regulation of vasomotor tone and structural support of these micro-vessels. When the vessels become muscularized, pulmonary vascular resistance increases, resulting in pulmonary artery hypertension.                                                 So recent studies have focused on pericytes in addition to pulmonary endothelial cells, smooth muscle cells, and fiberglass, but not much is known about the contribution of pulmonary pericytes to pulmonary arterial hypertension. Two genes are involved in Wnt planar cell polarity pathway that is responsible for coordinating complex cell movements during tissue morphogenesis. So, in this group, they have produced prior results that show that restoration of the Wnt planar cell polarity in pulmonary arterial hypertension, pericytes could partially restore recruitment to PNVECs and increase vessel stability.  Dr Carolyn Lam:               Interesting, and so that was their past research, and what did the current paper show?  Dr Greg Hundley:            Right. So Carolyn, what they found is that pulmonary microvascular endothelial cells isolated from pulmonary arterial hypertension patients, and endothelium from pulmonary arterial hypertension tissue have reduced expression of Wnt-5a. Healthy PMVECs produce and package Wnt-5a in the form of exosomes which regulate pericyte recruitment, motility, and polarity.                                                 And so, the overall implication is that promising therapeutic strategies that help can restore the Wnt/PCP, or planar cell polarity pathway, and endothelial pericyte communication could help prevent micro-vessel loss in patients with pulmonary artery hypertension.  Dr Carolyn Lam:               Thanks, Greg. So, I'm going to take us to the cath lab for this next paper. And it's the results of the CANTIC study, which aimed to answer the question, does intravenous P2Y12 inhibitor Cangrelor have a role in bridging the gap in platelet inhibition in patients with STEMI undergoing primary PCI. And this is from corresponding author Dr Angiolillo from the University of Florida College of Medicine Jacksonville and Colleagues.                                                 Now, CANTIC was a prospective randomized double-blind placebo control parallel design investigation of the pharmacal dynamic effects of Cangrelor versus placebo in patients undergoing primary PCI, who were also treated with crushed Ticagrelor. So, after diagnostic angiography, patients were randomized to a blinded two-hour infusion of either Cangrelor or placebo. At the same time, 180 milligrams of crushed Ticagrelor was administered to both groups. Platelet reactivity was measured with Verify Now P2Y12 point of care testing, and with vasodilator-stimulated phosphoprotein, or VASP.  Dr Greg Hundley:            So what did the trial show, Carolyn?  Dr Carolyn Lam:               They found that addition of Cangrelor led to more prompt and potent platelet inhibitory effects, compared with crushed Ticagrelor alone in patients undergoing primary PCI. The significant differences were observed as early as five minutes post bolus administration, and persisted until the end of its two-hour infusion.                                                 Furthermore, after discontinuation of Cangrelor or the placebo infusion, there were no differences in levels of platelet reactivity between groups. And this importantly rules out a drug/drug interaction when Cangrelor and Ticagrelor are concomitantly administered. This lack of drug-drug interaction is important, as it supports a more versatile use of Ticagrelor with respect to timing of its administration in patients treated concurrently with Cangrelor.                                                 Overall, the results are reassuring and demonstrate reduced platelet reactivity, and no high on treatment platelet reactivity with Cangrelor in combination with Ticagrelor in primary PCI patients. Of course, the implications of these pharmacal dynamic findings really warrant investigation in an adequately powered clinical trial.                                                 And that brings us to the end of our summaries. Let's go to our featured discussion.                                                 So PCI, or no PCI for chronic total occlusion, that is a perennial question isn't it? Especially nowadays when procedural results for PCI and CTO have improved in recent years, and PCI strategies have moved towards more complete revascularization. Yet the evidence is clearly lagging behind for us to make decisions on this. And that's why we're so happy that our featured paper today is the DECISION-CTO trial from Korea, and so happy to have the first author, Dr Seung-Whan Lee from ASA Medical Center to tell us about this, as well as our associate editor, Dr Manos Brilakis from UT Southwestern.                                                 So Dr Lee, could you tell us about the DECISION-CTO trial? Dr Seung-Whan Lee:       Yeah, in our trial our multicenter, randomized, noninferiority trial, PCI-eligible patients were assigned to receive either one of two strategies; PCI or no PCI or CTO. We did the option for PCI of the other. The primary endpoint as you know the composite outcome of deaths, myocardial infraction, stroke, or any revascularization. As related to quality of life was assessed up to three years. However, because of the slow recruitment, the trial was stopped before completion. We started 208 planned enrollments. For six years 834 patients there were randomly assigned to the CTO PCI versus no CTO PCI strategy.                                                 Among the patients assigned to the no CTO PCI strategy, nearly 20 percent of patient cross over to the CTO PCI. That is our big limitation, as you know. Anyways, the primary end point was assessed per year, and then, finally, we founded the per year risk of the major adverse cardiac events there’s no difference in contributor composite outcome, MI, revascularization, and stroke.                                                 However, in our trial, in some detail, in CTO PCI was success rate around 91 percent. However, complication is very low, .6 percent of patient is complication. Very surprisingly the coheir is up to the three, and no difference between CTO PCI versus no CTO PCI.                                                   I think our main message is our patient is a relatively low-risk population, including the syntax score 20 and the score 22%. The majority of patient preserved LV function and single-vessel disease 25%. The relative low risk population CTO PCI versus no CTO PCI clinical outcome is no difference of the per year from the two groups.                                                 I think that our trial is make the reposition with the medical law in the CTO patient. That’s my summary. Dr Carolyn Lam:                Thank you. Manos, could you maybe paint the background and let us know why this was so important for us to publish in Circulation? Why is it so difficult to do these trials?  Dr Manos Brilakis:           This is the largest study on CTO PCI so congratulations on getting this accomplished. I know it was many years and a lot of effort.                                                 I think a couple of things on the background. As Dr Lee said as well, CTO PCI success rates have been improved, and now at experienced centers you can get 85 to 90 percent success fairly consistently.                                                 The complication rates are low. .5 to 3 percent is the average rate. We do have a tool right now. The procedure is mature, and it's time test in the randomized trials.                                                 The question has always been for CTO PCI, "How does it help?" Does it improve symptoms? Does it improve the heart outcomes? Myocardial Infarction?  This is what DECISION CTO was trying to answer.                                                 Couple of I think limitations that we should take into account when interpreting the results. The first one is that these were notations with an isolated CTO, but a significant proportion had also multi-vessel disease. They were enrolled before treating the other vessels, which were subsequently treated.                                                 Sometimes it's hard to know how much the residual ischemia or symptoms would be present after the other lesions were treated. That's one thing.                                                 The second is that there was a significant crossover for about 1 in 5 patients that randomized to medical therapy immediately crossed over to the CTO PCI group. And that always uses the power and creates difficulty in interpreting the results.                                                 In my mind, the question still remains, in low risk populations it's possible that CTO PCI doesn't improve symptoms, but the ones that were expected to improve, the heart outcomes dec-MI, would be the high-risk patients with significant ischemia. Ideally, studies in the future should actually look specifically at patients who have high ischemia, significant symptoms when looking at heart outcomes.  Dr Carolyn Lam:               Dr Lee, I think you did mention as well in your manuscript that a viability test was not mandatory for patient enrollment. I mean, clearly it was such as work of labor enrolling such patients. If you put even more criteria it would have been impossible, I suppose. Do you have some thoughts there on maybe future studies? Dr Seung-Whan Lee:       Yeah, as you know, the currently ongoing CTO PCI process medical treatment is nobel CTO and ischemia CTO is assessed at the reduction of the ischemia burden in CTO PCI. I think there maybe two studies that give us some answer for the low level of the CTO PCI for the reduction of the ischemia.                                                 So, I think the larger ischemic burden the patient is maybe high risk to make the however we don’t know exactly the cut off… ischemic burden in CTO patient. Usually instable angina any kind…coronary disease…3 years circulation showed more than 10 percent of ischemic burden is really predictive of future cardiac event. However, we don't know exactly the can be applied to CTO patient. We don't know exactly.  Dr Manos Brilakis:           Can I ask Dr Lee a question regarding the study and his interpretation as well. Now the study was borrowed for hard end points dec MI. What his is perception, based on the DECISION CTO, and, of course, everything else in the literature and the CTO study with symptomatic benefit...Dr Lee, what is your conclusion about, or your kind of thoughts about, the effect of CTO PCI on improving symptoms, which is a more accepted indication for the procedure right now? Dr Seung-Whan Lee:       As you know, the university trials symptom assessment was done after the no CTO PCI. However, our trial is a pragmatic trial, initial approach to the CTO vessel and the vessels that is patient.                                                 At this moment, I think the other vessel, other no CTO vessel intervention and OMT may improve the patient symptom and then CTO vessel is the intervention including the CI patient completely…improve the symptom status. However, analysis showed up to the 3 year, maybe no difference between two groups in the CTO PCI versus medical treatment.                                                 Our trials of the CTO PCI symptom, we don't exactly the role of the after no CTO PCI. We don't know exactly the CTO based symptom assessment was not done, because of the symptom assessment was done before the intervention.                                                 I think that our trials are more practical, because of the initial…multivessel… CTO. Our trials, maybe, completely vascularization including CTO and no CTO vessel revascularization without the CTO intervention. Sometimes the patient to complain of symptom multivessel with the CTO I think we can wait if we continue the patient symptom…                                                 However, in this trial showed CTO specific intervention trial, because of the symptom assessment was done after no CTO vessel intervention. There is some improvement of the… receptor treatment satisfaction of the angina stability. I think that the CTO intervention is maybe reserved for the symptom control after the medical treatment failure of patient.                                                 I fully agree the symptom control is possible with the CTO PCI.  Dr Manos Brilakis:           Wonderful. Thank you. I think that's a critical differentiation that the DECISION CTO is not specific for CTO, but it's multi-vessel disease plus CTO. Thanks for clarifying. That's very important for the leaders and the entire community to understand that part.                                                 One more question, if it's okay. I know that in Asian countries bypass patients are relatively less. I think in the U.S. 50 percent. Any comment on that? I know people get less bypass in Asia than they do in the United States. How may that affect the interpretation of the DECISION CTO? Dr Seung-Whan Lee:       Initially, I introduced my studies to our patients syntax score under 20. As you know, the U.S. Registry shows the syntax score more than I think the 20, and the tester score around 46. Quite different in population, because the risk factor is quite different. U.S. patient is hypertension and diabetic are more prevalent than the Asian patient. Bypass surgery is 40 percent in Asian patients. Bypass surgery is around 102 percent in CTO registry. Quite big difference of the base rank, risk factor, and morbidity.                                                 I cannot apply to U.S. population exactly the same ... Not same situation. We cannot apply directly to the U.S. population. I fully agree with your suggestion, though. Lowest population is maybe ... Our trial is maybe lowest population. We agree.  Dr Carolyn Lam:               I'm just learning so much listening to both of your interventionists. What do you think are the take-home messages from this? Maybe, could I start with Dr Lee, and then give Manos the last word? Dr Seung-Whan Lee:       CTO PCI critical outcome, it should be tested as a large random trial. Maybe Manos already mentioned about the high-risk population, because our population is the lowest population. However, in some large random trial with a high-risk population we have consider some random trial because they are not easy.                                                 Maybe not easy to test in high-risk population. However, you must do that, because of the two established CTO PCI law in the current practice.  Dr Carolyn Lam:               Manos?  Dr Manos Brilakis:           Yeah, I would agree with that. I think the main conclusion regarding the field of CTO PCI is that still right now, the key indication remains symptom improvement. We do have the trials at this point showing that you do CTO PCI in terms of improving mortality. However, CTO PCI is a tool. It's a revascularization tool. Patients who have severe, complex, coronary disease, multi-vessel disease, may be best served with bypass in the first place. Those who have multi-vessel disease that's less complex and don't have significant symptoms after fixing the non-CTO lesions, then they may not benefit from CTO PCI as well. But those who have CTO lesions and have significant symptoms, this is the population for which I think there is general agreement, and I the decision that CTO is good with that, that those patients could benefit from CTO intervention.  Dr Carolyn Lam:               Thank you so much for sharing your insights.                                                 Thank you, listeners, for joining us today. You've been listening to Circulation on the Run. Don't forget to tune in again next week.                                                 This program is copyright American Heart Association 2019.  

In this episode, Dr. Perez discusses genetic markers in a population of Iberian gypsies, who are afflicted with a very severe form of pulmonary hypertension that is called pulmonary veno-occlusive disease. Vinicio de Jesus Perez, MD is Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF.  Learn more about clinical trials at: www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on facebook, twitter, instagram, youtube & linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD @PHatStanford

Jesus Perez with his Stoop story about adjusting to life in Baltimore after his family left Mexico and fighting for immigrant’s rights in the United States.

In this episode, Dr. Perez discusses health inequality and ways to improve access of care for patients with disadvantageous ethnic backgrounds. Vinicio de Jesus Perez, MD is Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF.  Learn more about pulmonary hypertension at www.phaware365.global. Never miss an episode with the phaware® podcast app. Follow us @phaware on facebook, twitter, instagram, youtube & linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD @PHatStanford

Vinicio de Jesus Perez, MD is Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF. He is principal investigator of a research program with the ultimate goal of identifying new therapeutic targets to treat PH and IPF. In this episode, Dr. Vinicio de Jesus Perez discusses pulmonary arterial hypertension as a complication of methamphetamine use (METH-PAH). Learn more about pulmonary hypertension at www.phaware365.global. Never miss an episode with the phaware® podcast app. Follow us @phaware on facebook, twitter, instagram, youtube & linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD @PHatStanford

Vinicio de Jesus Perez, MD is Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF. He is principal investigator of a research program with the ultimate goal of identifying new therapeutic targets to treat PH and IPF. In this episode, Dr. Vinicio de Jesus Perez discusses the 4th International Symposium: From Precision Biology to Precision Medicine in Pulmonary Hypertension. Learn more about pulmonary hypertension at www.phaware365.global. Never miss an episode with the phaware® podcast app. Follow us @phaware on facebook, twitter, instagram, youtube & linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD

Jesus makes his long awaited return to the show to talk about what's been going on in his life since he's last been on. We briefly discuss Infinity War (SPOILERS) and a range of topics including Quiet Place and what his thoughts on it was.Youtube Channel: https://www.youtube.com/channel/UCNPVfYWzlRTMFyG-qlmOKKw?view_as=subscriber

Are 800,000 people really about to get deported from America? With DACA getting rescinded, this week we sit with JESUS PEREZ, a dreamer, a board of directors member for CASA, and board member for Latino Providers Network and Baltimore Police Youth Advisors. He tells us his story of coming from Mexico as a toddler and growing up in the United States to face some harsh realities. This is the 18th episode of Strange Flavors, brought to you by Alif Theory. _____________________________________________ Email Us / Send Music: strangeflavorspodcast@gmail.com Facebook: http://facebook.com/StrangeFlavorsPodcast LINKS: CASA: http://wearecasa.org/ Losing GoPro in Texas Vlog: https://www.youtube.com/watch?v=rJzRdqo8g5w _____________________________________________ • FARAS • Tweet me: http://twitter.com/Farosty | @Farosty on IG/Snap/YouTube/FB • SHAH-AMEER • Tweet me: https://twitter.com/Shimmerwali | @Shimmerwali on IG/Snap/YouTube/FB • AMBER • Tweet me: http://twitter.com/ayeekhan | @ayeekhan on IG/Snap/YouTube/FB _____________________________________________ Music this week: 1. “Hold Me” - Olmos https://youtu.be/vf_S0-V6wTE 2. “Let Me Know” - Stupead https://youtu.be/Qq4w1YY47Po --- Send in a voice message: https://anchor.fm/strangeflavors/message Support this podcast: https://anchor.fm/strangeflavors/support

jesus perez de tedcas

D Decenas de miles de personas se manifestaron ante el Kremlin en Moscú para celebrar la futura anexión de Crimea a Rusia y mostrar el apoyo al ingreso de la península a la federación si así lo deciden los crimeos en el referéndum convocado para el 16 de Marzo de 2014. El Presidente de la Duma rusa anunció que los legisladores respaldarán el ingreso de Crimea a Rusia. El Presidente ejecutivo del monopolio Gazprom, Alexéi Miller, informó de que la compañía ucraniana Naftogaz, no ha pagado los suministros de Febrero y que su deuda ha aumentado a cerca de 1.400 millones de euros. "Nosotros siempre hemos cumplido nuestras obligaciones y lo seguiremos haciendo, pero no podemos suministrar el gas gratis". El diario El País titula en la pág. 5 que el El Gobierno ucranio confía en el que el "mundo civilizado" rechace la secesión. El magistrado del Tribunal Supremo Gilbert Azibert está siendo investigado por la Justicia francesa por haber informado a Sarkozy de la evolución del caso L´Oreal y Tapie y haber recibido una sinecura en Mónaco gracias a su mediación. Soraya Saenz de Santamaria, dijo en la rueda de prensa de Consejo de Ministros que el referéndum en Crimea está prohibido por la Ley Internacional. Nos preguntamos donde está esa Ley Internacional. Ha presentado el programa Adrian Perales, con el análisis de Antonio Garcia-Trevijano, invitados Elena y Jesus Perez, ciudadanos rusos, y la ayuda técnica de Pedro Gómez y Manuel Ramos.

D Decenas de miles de personas se manifestaron ante el Kremlin en Moscú para celebrar la futura anexión de Crimea a Rusia y mostrar el apoyo al ingreso de la península a la federación si así lo deciden los crimeos en el referéndum convocado para el 16 de Marzo de 2014. El Presidente de la Duma rusa anunció que los legisladores respaldarán el ingreso de Crimea a Rusia. El Presidente ejecutivo del monopolio Gazprom, Alexéi Miller, informó de que la compañía ucraniana Naftogaz, no ha pagado los suministros de Febrero y que su deuda ha aumentado a cerca de 1.400 millones de euros. "Nosotros siempre hemos cumplido nuestras obligaciones y lo seguiremos haciendo, pero no podemos suministrar el gas gratis". El diario El País titula en la pág. 5 que el El Gobierno ucranio confía en el que el "mundo civilizado" rechace la secesión. El magistrado del Tribunal Supremo Gilbert Azibert está siendo investigado por la Justicia francesa por haber informado a Sarkozy de la evolución del caso L´Oreal y Tapie y haber recibido una sinecura en Mónaco gracias a su mediación. Soraya Saenz de Santamaria, dijo en la rueda de prensa de Consejo de Ministros que el referéndum en Crimea está prohibido por la Ley Internacional. Nos preguntamos donde está esa Ley Internacional. Ha presentado el programa Adrian Perales, con el análisis de Antonio Garcia-Trevijano, invitados Elena y Jesus Perez, ciudadanos rusos, y la ayuda técnica de Pedro Gómez y Manuel Ramos.

  Normalmente tenemos muchas ganas de reunirnos para grabar, pues esta vez la que mas. Venimos como niños con su juguete nuevo. Todo se disfruta mas cuando es inesperado. Y hasta que nos hemos sentado delante de los micros, creo que no nos dimos cuenta del reconocimiento. Personalmente me costó empezar a soltar palabras por esta boquita. Además venimos con los votos renovados desde la ultima Jornadas de podcasting celebradas en Sevilla recientemente y llenos de amor por encontrarnos con tantos amigos , por hacer algunos nuevos y por ponerle cara a muchos oyentes. Esto último no tiene precio, poder charlar con oyentes y recordar capítulos entre risas y algunas cervezas. Por otra parte, también muy ilusionados e impacientes por presentaros al nuevo integrante del podcast. Juande , @Juandeochpu en twitter (bastante conocido diria yo). No ha sido una elección a la ligera ya que tenia buena competencia y estamos seguros que muy pronto os parecerá imprescindible. En esta ocasión abrumado por la responsabilidad y su poquito de nervios ya nos muestra que es un cachondo.     - LA TABERNA:  Lo que hacemos por el podcasting, para esta ocasión hasta nos hemos tenido que leer un libro. Pero nos las van a pagar. Se nos ha quedado amariconado medio cerebro. Cogemos el libro “Cincuenta sombras de Grey” y le damos poca a esa novela rosa. Y todo por enterarnos a ver que leches tenia este libro para armar ese revuelo en medio mundo. - MIS VECINITAS:  Imagino que a esta categoría de mujeres  muchos le tenían ganas.  Así que espero que lo aprovechéis para seguir poniendo candidatas en los comentarios.                                                        CHICA TWITTER  ——->      @_sexsymbol_   Volvemos a tener oyentes que nos mandan su vecinita desafiándonos.                                          Y nuestros oyentes nos mandan                                                                       *Sobre esta linea hay una transición de fotos en Flash y que es posible que no veas si lo haces desde un dispositivo Apple, si es así pincha  AQUÍ   - HACIENDO AMIGOS:  Como no podía ser de otra manera, esta sección la hemos dedicado a ponerle los dientes largos a todo aquel que no pudo asistir a las Jpod´12.    - CORREOS, RECORDATORIOS Y NOMBRAMIENTOS OYENTES VIP:   Leeremos correos de Manuela Vega, Esteban y Raul donde nos felicitan por el premio y nosotros lo tomamos como un par de besitos en la carita, gracias. Y un magnifico audio correo de Jesus Perez (@jesulin_guapin) que ponemosen la sección de La taberna.   Nombramientos VIP Karterre                                      merito–> Comentarios en itunes   Rafa-CBF                                     merito–> Comentario en Ivoox(9)   Y atentos para el siguiente podcast que os presentaremos el nuevo proyecto llamado “OBJETIVO LAS VEGAS”. No digo mas.     Y no os olvidéis comentar qué chica os ha gustado más.   Note: There is a poll embedded within this post, please visit the site to participate in this post's poll.